Literature DB >> 9134638

Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.

A N Blanco1, M A Cardozo, M Candela, M T Santarelli, R Pérez Bianco, M A Lazzari.   

Abstract

In a study of 170 haemophilia A patients, 43 were found to have an inhibitory effect; seven had anti-factor VIII inhibitors (a-fVIII)(A), 18 had lupus anticoagulants (LAs) with a strong (B: 12) or weak (C: 6) time-dependent effect and 18 had no time-dependent LAs (D). The a-fVIII showed a neutralizing effect only against factor VIII and negative diluted Russell viper venom time (dRVVT). The LAs were diagnosed by dRVVT; the Staclot LA agreed with the dRVVT. During the study, three patients changed from an a-fVIII to an LA pattern; they also modified their clinical response. Our prevalence of a-fVIII was low (4%) and we found 21% of LA, with a high (50%) prevalence of time-dependent inhibition. This pattern raises the possibility of the coexistence of LA and a-fVIII, stressing the need to develop specific tests to identify a-fVIII and LA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134638

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time.

Authors:  Akpan Spencer; Michael I Pearce; Paul Rj Ames
Journal:  Thromb J       Date:  2011-10-27

Review 2.  Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.

Authors:  C H Miller
Journal:  Haemophilia       Date:  2018-02-15       Impact factor: 4.287

Review 3.  Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice.

Authors:  Allyson M Pishko; Bhavya S Doshi
Journal:  J Blood Med       Date:  2022-05-11

Review 4.  Immune response to FVIII in hemophilia A: an overview of risk factors.

Authors:  Kanjaksha Ghosh; Shrimati Shetty
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

5.  International recommendations on the diagnosis and treatment of acquired hemophilia A.

Authors:  Andreas Tiede; Peter Collins; Paul Knoebl; Jerome Teitel; Craig Kessler; Midori Shima; Giovanni Di Minno; Roseline d'Oiron; Peter Salaj; Victor Jiménez-Yuste; Angela Huth-Kühne; Paul Giangrande
Journal:  Haematologica       Date:  2020-05-07       Impact factor: 9.941

6.  [Chinese guidelines on the diagnosis and treatment of acquired hemophilia A (2021)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.